Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation.

ABSTRACT:

Purpose

The aim of this study is to report the 6-month results after one intravitreal ranibizumab (IVR) injection followed by pro re nata dosing for macular edema (ME) after branch retinal vein occlusion.

Patients and methods

The inclusion criteria included a minimal patient age of 18 years, 20 letters or more best-corrected visual acuity (BCVA) (Early Treatment Diabetic Retinopathy Study [ETDRS] score, 77 letters or less), and central retinal thickness (CRT) of 250 microns or more. The primary outcome measure was the mean BCVA change from baseline at month 6; the secondary outcomes were mean changes in CRT, residual ME, and microaneurysm formation.

Results

Twenty patients were enrolled from March 2014 through October 2016 at Nagoya City University Hospital. The basel

SUBMITTER: Kawamura M 

PROVIDER: S-EPMC6108404 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature